Cargando…
Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis
We evaluated the effect of intravenous immunoglobulin (IVIG) on mortality in clindamycin-treated streptococcal toxic shock syndrome using a meta-analysis. In association with IVIG, mortality fell from 33.7% to 15.7% with remarkable consistency across the single randomized and four nonrandomized stud...
Autores principales: | Parks, Tom, Wilson, Clare, Curtis, Nigel, Norrby-Teglund, Anna, Sriskandan, Shiranee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186853/ https://www.ncbi.nlm.nih.gov/pubmed/29788397 http://dx.doi.org/10.1093/cid/ciy401 |
Ejemplares similares
-
Editorial Commentary: Step on the GAS: Are We Almost There for Clindamycin and Intravenous Immunoglobulin?
por: Tan, Lionel K. K., et al.
Publicado: (2014) -
Superantigens and Streptococcal Toxic Shock Syndrome
por: Proft, Thomas, et al.
Publicado: (2003) -
Invasive Group A Streptococcal Infections: Benefit of Clindamycin, Intravenous Immunoglobulins and Secondary Prophylaxis
por: Laho, Delphine, et al.
Publicado: (2021) -
Bacterial Phenotype Variants in Group B Streptococcal Toxic Shock Syndrome
por: Sendi, Parham, et al.
Publicado: (2009) -
MAIT Cells Are Major Contributors to the Cytokine Response in Group A Streptococcal Toxic Shock Syndrome
por: Emgård, Johanna, et al.
Publicado: (2019)